We set out to use the fatty-acid rescue strategy with several such compounds, as a means of both testing the hypothesis that fatty acid synthesis, and SCD1 activity in particular, are necessary for cancer cell viability, and also with the goal of better understanding the on- and off-mechanism activities of the fatty-acid synthesis inhibitors themselves. Here, SCD is linked to cancer.